Fosun To Buy KKR-Backed Indian Drug Co. For Up To $1.3B
Shanghai Fosun Pharmaceutical Group Co. Ltd. will buy a significant stake in Gland Pharma Ltd., an Indian company that manufactures generic injectable drugs for U.S. and Indian markets, from KKR &...To view the full article, register now.
Already a subscriber? Click here to view full article